GlaxoSmithKline Gets U.S. Antitrust Approval for Stiefel Laboratories

Bookmark and Share

Reuters -- GlaxoSmithKline (GSK.L) received U.S. antitrust approval to buy privately-held skincare company Stiefel Laboratories Inc, U.S. officials said on Tuesday.

MORE ON THIS TOPIC